Juan Carlos Martinez-Gutierrez

Juan Carlos Martinez-Gutierrez

Auto-generated profile, based on publicly available information

Juan Carlos Martinez-Gutierrez

Department of Neuroradiology, University of Texas Health Science Center at Houston, Houston, Texas, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SBStephen B. Beres
Stephen B. Beres
RCRonan K. Carroll
Ronan K. Carroll
PSPatrick Shea
Patrick Shea
ISIzabela Sitkiewicz
Izabela Sitkiewicz
JMJuan Carlos Martinez-Gutierrez
Juan Carlos Martinez-Gutierrez
JMJames M. Musser
James M. Musser
Understanding the fine-structure molecular architecture of bacterial epidemics has been a long-sought goal of infectious disease research. We used short-read-length DNA sequencing coupled with mass spectroscopy analysis of SNPs to study the molecular pathogenomics of three successive epidemics of invasive infections involving 344 serotype M3 group A Streptococcus in Ontario, Canada. Sequencing the genome of 95 strains from the three epidemics, coupled with analysis of 280 biallelic SNPs in all 344 strains, revealed an unexpectedly complex population structure composed of a dynamic mixture of distinct clonally related complexes. We discovered that each epidemic is dominated by micro- and macrobursts of multiple emergent clones, some with distinct strain genotype–patient phenotype relationships. On average, strains were differentiated from one another by only 49 SNPs and 11 insertion-deletion events (indels) in the core genome. Ten percent of SNPs are strain specific; that is, each strain has a unique genome sequence. We identified nonrandom temporal–spatial patterns of strain distribution within and between the epidemic peaks. The extensive full-genome data permitted us to identify genes with significantly increased rates of nonsynonymous (amino acid-altering) nucleotide polymorphisms, thereby providing clues about selective forces operative in the host. Comparative expression microarray analysis revealed that closely related strains differentiated by seemingly modest genetic changes can have significantly divergent transcriptomes. We conclude that enhanced understanding of bacterial epidemics requires a deep-sequencing, geographically centric, comparative pathogenomics strategy.

7 March 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PSPatrick Shea
Patrick Shea
SBStephen B. Beres
Stephen B. Beres
AFAnthony R. Flores
Anthony R. Flores
AEAmy L. Ewbank
Amy L. Ewbank
JGJavier H. Gonzalez-Lugo
Javier H. Gonzalez-Lugo
JMJames M. Musser
James M. Musser
Many pathogens colonize different anatomical sites, but the selective pressures contributing to survival in the diverse niches are poorly understood. Group A Streptococcus (GAS) is a human-adapted bacterium that causes a range of infections. Much effort has been expended to dissect the molecular basis of invasive (sterile-site) infections, but little is known about the genomes of strains causing pharyngitis (streptococcal “sore throat”). Additionally, there is essentially nothing known about the genetic relationships between populations of invasive and pharyngitis strains. In particular, it is unclear if invasive strains represent a distinct genetic subpopulation of strains that cause pharyngitis. We compared the genomes of 86 serotype M3 GAS pharyngitis strains with those of 215 invasive M3 strains from the same geographical location. The pharyngitis and invasive groups were highly related to each other and had virtually identical phylogenetic structures, indicating they belong to the same genetic pool. Despite the overall high degree of genetic similarity, we discovered that strains from different host environments (i.e., throat, normally sterile sites) have distinct patterns of diversifying selection at the nucleotide level. In particular, the pattern of polymorphisms in the hyaluronic acid capsule synthesis operon was especially different between the two strain populations. This finding was mirrored by data obtained from full-genome analysis of strains sequentially cultured from nonhuman primates. Our results answer the long-standing question of the genetic relationship between GAS pharyngitis and invasive strains. The data provide previously undescribed information about the evolutionary history of pathogenic microbes that cause disease in different anatomical sites.

1 March 2013 in Neurological Research
Verified
Journal Article
Closed access
KCKaisorn L. Chaichana
Kaisorn L. Chaichana
CPCourtney Pendleton
Courtney Pendleton
CJChristopher Jackson
Christopher Jackson
JMJuan Carlos Martinez-Gutierrez
Juan Carlos Martinez-Gutierrez
ADAndrea Diaz-Stransky
Andrea Diaz-Stransky
AQAlfredo Quinones-Hinojosa
Alfredo Quinones-Hinojosa
Objective: The development of venothromboembolisms (VTEs), including deep vein thrombosis (DVT) and pulmonary emboli (PE), is common in brain tumor patients. Their development can be catastrophic. Studies evaluating pre-operative clinical factors that predispose patients to the development of VTE are few and limited. An understanding may help risk stratify patients and guide subsequent therapy aimed at reducing the risk of DVTs/PEs. Methods: All adult patients who underwent surgery for an intracranial tumor at an academic tertiary care institution between 1998 and 2008 were retrospectively reviewed. Stepwise multivariate logistical regression analysis was used to identify pre-operative factors associated with the development of peri-operative (within 30 days of surgery) DVTs/PEs among patients who underwent surgery of their intracranial tumor. Results: Of the 4293 patients in this study, 126 (3%) patients developed DVT and/or PE in the peri-operative period. The pre-operative factors independently associated with the development of DVTs/PEs were: poorer Karnofsky performance scale (KPS) [odds ratio (OR), 1·040; 95% confidence interval (CI), 1·026–1·052; P<0·0001], high grade glioma (OR, 1·702; 95% CI, 1·176–2·465; P = 0·005), older age (OR, 1·033; 95% CI, 1·020–1·046; P<0·0001), hypertension (OR, 1·785; 95% CI, 1·180–2·699; P = 0·006), and motor deficit (OR, 1·854; 95% CI, 1·244–2·763; P = 0·002). Eighty six per cent of the patients with DVTs/PEs were treated with either unfractionated or low molecular weight heparin, and 4% of these patients developed intracranial hemorrhage. Discussion: The present study found that poorer functional status, older age, pre-operative motor deficit, high grade glioma, and hypertension each independently increased the risk of developing peri-operative DVTs/PEs. These findings may provide patients and physicians with prognostic information that may guide therapies aimed at minimizing the development of peri-operative DVTs/PEs.

1 November 2011 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PSPatrick Shea
Patrick Shea
AEAmy Ewbank
Amy Ewbank
JGJavier Gonzalez-Lugo
Javier Gonzalez-Lugo
AMAlexandro Martagón
Alexandro Martagón
JMJuan Martinez-Gutierrez
Juan Martinez-Gutierrez
JMJames Musser
James Musser
Group A Streptococcus (GAS) is a human-adapted pathogen that causes a variety of diseases, including pharyngitis and invasive infections. GAS strains are categorized by variation in the nucleotide sequence of the gene (emm) that encodes the M protein. To identify the emm types of GAS strains causing pharyngitis in Ontario, Canada, we sequenced the hypervariable region of the emm gene in 4,635 pharyngeal GAS isolates collected during 2002–2010. The most prevalent emm types varied little from year to year. In contrast, fine-scale geographic analysis identified inter-site variability in the most common emm types. Additionally, we observed fluctuations in yearly frequency of emm3 strains from pharyngitis patients that coincided with peaks of emm3 invasive infections. We also discovered a striking increase in frequency of emm89 strains among isolates from patients with pharyngitis and invasive disease. These findings about the epidemiology of GAS are potentially useful for vaccine research.

9 September 2022 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Open access
PDF file
HKHyun Woo Kim
Hyun Woo Kim
RRRobert William Regenhardt
Robert William Regenhardt
SDSalvatore A D'Amato
Salvatore A D'Amato
MNMichael I Nahhas
Michael I Nahhas
Adam DmytriwAdam Dmytriw
Adam Dmytriw
JMJuan Carlos Martinez-Gutierrez
Juan Carlos Martinez-Gutierrez
Carotid artery stenosis is a leading cause of ischemic stroke. While management of symptomatic carotid stenosis is well established, the optimal approach in asymptomatic carotid artery stenosis (aCAS) remains controversial. The rapid evolution of medical therapies within the time frame of existing landmark aCAS surgical revascularization trials has rendered their findings outdated. In this review, we sought to summarize the controversies in the management of aCAS by providing the most up-to-date medical and surgical evidence. Subsequently, we compile the evidence surrounding high-risk clinical and imaging features that might identify higher-risk lesions. With this, we aim to provide a practical framework for a precision medicine approach to the management of aCAS.

1 May 2023 in Stroke
Verified
Journal Article
Closed access
PDF file
CRChristopher T. Richards
Christopher T. Richards
JOJ. Adam Oostema
J. Adam Oostema
SCSherita N. Chapman
Sherita N. Chapman
LMLauren E. Mamer
Lauren E. Mamer
EBEthan S. Brandler
Ethan S. Brandler
KZKori S. Zachrison
Kori S. Zachrison
The prehospital phase is a critical component of delivering high-quality acute stroke care. This topical review discusses the current state of prehospital acute stroke screening and transport, as well as new and emerging advances in prehospital diagnosis and treatment of acute stroke. Topics include prehospital stroke screening, stroke severity screening, emerging technologies to aid in the identification and diagnosis of acute stroke in the prehospital setting, prenotification of receiving emergency departments, decision support for destination determination, and the capabilities and opportunities for prehospital stroke treatment in mobile stroke units. Further evidence-based guideline development and implementation of new technologies are critical for ongoing improvements in prehospital stroke care.